Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Surrozen (SRZNW) Shares Outstanding (Diluted Average) (2021 - 2025)

Historic Shares Outstanding (Diluted Average) for Surrozen (SRZNW) over the last 5 years, with Q3 2025 value amounting to $8571.0.

  • Surrozen's Shares Outstanding (Diluted Average) rose 16552.04% to $8571.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $8571.0, marking a year-over-year increase of 16552.04%. This contributed to the annual value of $2933.0 for FY2024, which is 4534.19% up from last year.
  • Latest data reveals that Surrozen reported Shares Outstanding (Diluted Average) of $8571.0 as of Q3 2025, which was up 16552.04% from $8541.0 recorded in Q2 2025.
  • In the past 5 years, Surrozen's Shares Outstanding (Diluted Average) ranged from a high of $35.0 million in Q3 2022 and a low of $1998.0 during Q1 2023
  • For the 5-year period, Surrozen's Shares Outstanding (Diluted Average) averaged around $8.6 million, with its median value being $8556.0 (2025).
  • As far as peak fluctuations go, Surrozen's Shares Outstanding (Diluted Average) tumbled by 9999.43% in 2023, and later soared by 17011.39% in 2025.
  • Quarter analysis of 5 years shows Surrozen's Shares Outstanding (Diluted Average) stood at $24689.0 in 2021, then tumbled by 90.63% to $2314.0 in 2022, then dropped by 12.79% to $2018.0 in 2023, then skyrocketed by 45.34% to $2933.0 in 2024, then soared by 192.23% to $8571.0 in 2025.
  • Its Shares Outstanding (Diluted Average) was $8571.0 in Q3 2025, compared to $8541.0 in Q2 2025 and $3628.0 in Q1 2025.